肾衰竭患者抑郁筛查工具的系统综述
该系统综述检索了MEDLINE、PsycINFO等数据库(截至2020年6月),纳入16项评估肾衰竭患者抑郁筛查工具诊断准确性的研究。Beck抑郁量表II研究最多但阈值差异大,患者健康问卷9和老年抑郁量表15表现良好但研究不足,多数工具证据有限且可能不适用于美国人群。
要点
- Beck抑郁量表II是研究最多的工具,但阈值范围宽泛。
- 患者健康问卷9和老年抑郁量表15表现良好但研究不足。
- Beck抑郁量表快速筛查版或可作为初筛选择。
核心结论
- 大多数抑郁筛查工具在肾衰竭患者中的诊断准确性研究有限,现有研究可能不适用于美国人群。
研究设计与样本
- 系统综述,检索MEDLINE、PsycINFO等数据库从建库至2020年6月,纳入16项比较筛查工具与临床访谈或另一验证工具的研究。
主要发现
- Beck抑郁量表II研究最多,报告了宽泛的阈值范围。
- 患者健康问卷9和老年抑郁量表15(60岁以上成人)表现良好但研究不足。
- Beck抑郁量表快速筛查版可能作为初始筛查的良好选择。
关键数值与推荐
- 提取了灵敏度、特异度、阳性预测值、阴性预测值和曲线下面积数据。
- 使用QUADAS-2评估偏倚风险。
临床怎么用
- 可考虑使用Beck抑郁量表快速筛查版进行初始筛查。
- 患者健康问卷9和老年抑郁量表15可作为选项但需注意研究证据有限。
局限性
- 现有研究存在方法学质量和/或报告方面的局限性。
- 研究结果可能无法推广至美国人群。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND AND OBJECTIVES: Patients with kidney failure experience depression at rates higher than the general population. Despite the Centers for Medicare and Medicaid Services' ESRD Quality Incentive Program requirements for routine depression screening for patients with kidney failure, no clear guidance exists. DESIGN, SETTING, PARTICIPANTS, & MEASUREMENTS: For this systematic review, we searched MEDLINE, PsycINFO, and other databases from inception to June 2020. Two investigators screened all abstracts and full text. We included studies assessing patients with kidney failure and compared a tool to a clinical interview or another validated tool (e.g., Beck Depression Inventory II). We abstracted data related to sensitivity and specificity, positive and negative predictive value, and the area under the curve. We evaluated the risk of bias using the Quality Assessment of Diagnostic Accuracy Studies 2. RESULTS: A total of 16 studies evaluated the performance characteristics of depression assessment tools for patients with kidney failure. The Beck Depression Inventory II was by far the best studied. A wide range of thresholds were reported. Shorter tools in the public domain such as the Patient Health Questionnaire 9 and Geriatric Depression Scale 15 (adults over 60) performed well but were not well studied. Short tools such as the Beck Depression Inventory-Fast Screen may be a good option for an initial screen. CONCLUSIONS: There is limited research evaluating the diagnostic accuracy of most screening tools for depression in patients with kidney failure, and existing studies may not be generalizable to US populations. Studies suffer from limitations related to methodology quality and/or reporting. Future research should target widely used, free tools such as the Patient Health Questionnaire 2 and the Patient Health Questionnaire 9. CLINICAL TRIAL REGISTRY NAME AND REGISTRATION NUMBER: Systematic Review Registration: PROSPERO CRD42020140227.
引用
- Kondo K, Antick JR, Ayers CK, et al. Depression Screening Tools for Patients with Kidney Failure: A Systematic Review. Clin J Am Soc Nephrol. 2020. PMID: 33203736. doi:10.2215/CJN.05540420
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。